Canadabis Capital has recently completed a successful shipment of its cannabis products to Portugal, which includes a selection of cannabis products from Stigma Grow.

CanadaBis is the parent company of cannabis brands like Stigma Grow and Dab Bods and companies like Stigma Roots, Goldstream Cannabis, and the INDICAtive Collection.

“This is a historic moment not only for Stigma Grow but for Canadabis Capital as a whole,” said Travis Mcintyre, CEO of Canadabis Capital. “Our successful entry into the Portuguese market is a reflection of our hard work, strategic planning, and the unwavering support of our partners and stakeholders. We are excited to introduce our high-quality products to European consumers and contribute to the growth of the cannabis industry in Portugal.”

The company says the first shipment to Portugal highlights Stigma Grow’s product line and underscores its vision of expanding its global footprint to regions like Europe. 

In its most recent quarterly report, CanadaBis Capital Inc. reported gross revenue of $9.6 million and net revenue of $5 million for the three months ended October 31, 2024 (Q1 2025), with net income of $321,569.

In addition to the company’s sale of cannabis concentrates and extracts, flower, and pre-rolls, CanadaBis provides third-party and white-label processing contracts, including product development R&D.

The company currently owns a 66,000-square-foot facility, of which approximately 44,000 square feet of the building has been developed and equipped for the capacity to grow 225 kg of cannabis per year. The majority of its footprint is equipped and being used for the production of cannabis products such as extracts and infused pre-rolls.

The Alberta-based company also stated in the most recent quarterly report (page 3) from 2024 that it was in the process of shipping its first international products to the European market.

Related Articles

CanadaBis realizes highest gross revenue in Q1 2025

December 31, 2024

CanadaBis Capital reports decline in net income

November 28, 2024

CanadaBis continues trend of profitability with focus on pre-rolls and extracts

June 26, 2024